| Quantro Therapeutics GmbH. (7/21/20). "Press Release: Quantro Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform". Vienna. |
2020-07-21 |
| DeepSpin GmbH. (6/30/20). "Press Release: Berlin-based DeepSpin Raises Seed Round to Revolutionize Medical Imaging". Berlin. |
2020-06-30 |
| Apeiron Biologics AG. (6/3/20). "Press Release: Apeiron Biologics Closes Oversubscribed Financing Round of EUR 17.5 Million for the Development of APN01 against COVID-19". Vienna. |
2020-06-03 |
| Delta 4 GmbH. (6/2/20). "Press Release: Delta 4 Announces Results Achieved with Drug Discovery Platform". Vienna. |
2020-06-02 |
| Merck & Co., Inc.. (5/26/20). "Press Release: Merck to Acquire Themis". Kenilworth, NJ. |
2020-05-26 |
| Apeiron Biologics AG. (5/18/20). "Press Release: Apeiron Biologics Announces Financing Round for the Further Development of the COVID-19 Drug APN01". Vienna. |
2020-05-18 |
| Apeptico Forschung und Entwicklung GmbH. (4/7/20). "Press Release: Solatide Has Been Approved by the Austrian Federal Office for Safety in Health Care for the Treatment of COVID-19 Patients with Severe Pulmonary Dysfunction". Vienna. |
2020-04-07 |
| Evotec SE. (4/6/20). "Press Release: Evotec Expands into Gene Therapy. Evotec Establishes Gene Therapy R&D Site with more than 20 Experienced Scientis in Austria". Hamburg. |
2020-04-06 |
| Evotec SE. (4/6/20). "Press Release: Evotec and Takeda Enter into Multi-year Gene Therapy Research Alliance". Hamburg. |
2020-04-06 |
| Apeiron Biologics AG. (4/2/20). "Press Release: Apeiron Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19". Vienna. |
2020-04-02 |
| OncoOne GmbH. (3/18/20). "Press Release: OncoOne Launches with EUR 13 Million Series A to Develop Multiple Drug Modalities for Unexplored Target". Klosterneuburg. |
2020-03-18 |
| Calyxha Biotechnologies GmbH. (3/4/20). "Press Release: Calyxha Endeavors to Develop Novel Approaches to Tissue Degenerative Diseases and Receives Support from Austrian VC and International Investors". Vienna. |
2020-03-04 |
| ERS Genomics Ltd.. (2/11/20). "Press Release: ERS Genomics and Aelian Biotechnology Announce CRISPR/Cas9 License Agreement Enabling Aelian’s Unique Screening Platform". Dublin & Vienna. |
2020-02-11 |
| CellTool GmbH. (1/20/20). "Press Release: CellTool Appoints Wulf Fischer-Knuppertz as CEO". Tutzing. |
2020-01-20 |
| Innate Pharma S.A.. (12/13/19). "Press Release: Innate Pharma Provides Update on Lacutamab TELLOMAK Trial". Marseille. |
2019-12-13 |
| SHS Gesellschaft für Beteiligungsmanagement mbH. (11/26/19). "Press Release: Establishing a New Standard for the Life Science Industry. SHS Supports Internationalization and Further Growth of Single Use Support". Tübingen & Kufstein. |
2019-11-26 |
| Themis Bioscience GmbH. (10/29/19). "Press Release: Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine". Vienna & Oslo. |
2019-10-29 |
| Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen. |
2019-10-28 |
| PhagoMed Biopharma GmbH. (10/22/19). "Press Release: Phage Lysin Stabilzes Vaginal Microbiome. PhageMed Accelerates R6D Program against Bacterial Vaginosis". Vienna. |
2019-10-22 |
| Blueprint Genetics Oy. (9/24/19). "Press Release: Blueprint Genetics and ArchimedLife Form a Partnership to Launch High Quality Biochemical Testing for Rare Diseases in North America". |
2019-09-24 |
| Themis Bioscience GmbH. (9/18/19). "Press Release: Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline". Vienna. |
2019-09-18 |
| Curetis N.V.. (9/16/19). "Press Release: Curetis Group Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation". Holzgerlingen & Vienna. |
2019-09-16 |
| Biocrates Life Sciences AG. (9/12/19). "Press Release: Repositioning of Biocrates – Management Change and New Round of Financing". Innsbruck. |
2019-09-12 |
| Themis Bioscience GmbH. (8/22/19). "Press Release: Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates". Vienna. |
2019-08-22 |
| Curetis N.V.. (8/8/19). "Press Release: Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing". Vienna & Holzgerlingen. |
2019-08-08 |
| IMBA – Institute of Molecular Biotechnology GmbH. (8/7/19). "Press Release: a:head bio – Launched to Transform CNS Drug Discovery". |
2019-08-07 |
| Platomics GmbH. (8/6/19). "Press Release: 7-digit Investment in Future Technology Genetic Testing". |
2019-08-06 |
| PhagoMed Biopharma GmbH. (6/27/19). "Press Release: Further Investment for PhagoMed. Investors Support Phage Therapy". Vienna. |
2019-06-27 |
| Themis Bioscience GmbH. (6/4/19). "Press Release: CEPI Awards up to US$21 Million to Themis Bioscience for Phase 3 Chikungunya Vaccine Development". Vienna & Oslo. |
2019-06-04 |
| ERS Genomics Ltd.. (4/23/19). "Press Release: US Patent Office Grants Charpentier/Doudna Key CRISPR Patent". Dublin. |
2019-04-23 |
| Curetis N.V.. (4/12/19). "Press Release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019". Vienna, Holzgerlingen & Amsterdam. |
2019-04-12 |
| Curetis N.V.. (4/4/19). "Press Release: Study Data Presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform". Amsterdam, San Diego, CA & Holzgerlingen. |
2019-04-04 |
| Curetis N.V.. (4/2/19). "Press Release: Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance". Amsterdam & Holzgerlingen. |
2019-04-02 |
| Themis Bioscience GmbH. (2/25/19). "Press Release: Themis Bioscience Receives FDA Fast Track Designation for Chikungunya Vaccine Candidate". Vienna. |
2019-02-25 |
| Curetis N.V.. (2/18/19). "Press Release: Curetis’ Subsidiary Ares Genetics and Qiagen Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance". Vienna, Holzgerlingen & Amsterdam. |
2019-02-18 |
| Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Sets Offer Price at 75 Euro per Share (Adhoc-News)". |
2019-01-29 |
| Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Announces Strong Investor Demand and Expected Offer Price (Adhoc-News)". |
2019-01-29 |
| Marinomed Biotech AG. (1/23/19). "Press Release: Marinomed Resumes Offer Period of the IPO (Adhoc-News)". |
2019-01-23 |
| Marinomed Biotech AG. (1/21/19). "Press Release: Partnership in China and EIB Financing [Not for US, AU, CA, JP or any other jurisdiction where prohibited by applicable law]". Vienna. |
2019-01-21 |
| Curetis N.V.. (1/8/19). "Press Release: Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test". Vienna, Amsterdam & Holzgerlingen. |
2019-01-08 |
| Valneva S.E.. (1/7/19). "Press Release: Valneva Announces Its Intention to Delist from the Vienna Stock Exchange. Trading Will Be Centralized on Euronext Paris". Saint-Herblain. |
2019-01-07 |
| Bruker Corporation. (12/18/18). "Press Release: Bruker Completes the Acquisition of Alicona Imaging GmbH". Billerica, MA. |
2018-12-18 |
| Curetis N.V.. (12/18/18). "Press Release: Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance". Vienna, Holzgerlingen & Amsterdam. |
2018-12-18 |
| Curetis N.V.. (12/13/18). "Press Release: Curetis Sharpens Focus on Near-term Strategic Value Drivers. Business Focus on U.S. Commercialization, Strategic Partnering, Ares Genetics and Asset Monetization". Amsterdam, Holzgerlingen & San Diego, CA. |
2018-12-13 |
| SGS S.A.. (12/12/18). "Press Release: SGS Invests in Imprint Analytics, Austria". |
2018-12-12 |
| Marinomed Biotech AG. (11/29/18). "Press Release: Marinomed Suspends Offer Period of the Current IPO [Adhoc-News]". |
2018-11-29 |
| Marinomed Biotech AG. (11/28/18). "Press Release: Viennese Biotech Company Marinomed Demonstrates the Benefits of Its Patented Marinosolv Technology". |
2018-11-28 |
| Marinomed Biotech AG. (11/16/18). "Press Release: Marinomed Determines IPO Timeline and Terms [Adhoc-News]". |
2018-11-16 |
| Bruker Corporation. (11/14/18). "Press Release: Bruker Announces Agreement for the Acquisition of Alicona Imaging GmbH". Billerica. |
2018-11-14 |
| Marinomed Biotech AG. (11/5/18). "Press Release: Marinomed Announces Its Intention to Launch an Initial Public Offering and Listing on the Vienna Stock Exchange [Not for US, AU, CA, JP, et al.]". Vienna. |
2018-11-05 |
| Themis Bioscience GmbH. (11/5/18). "Press Release: Themis Bioscience Publishes Compelling Phase 2 Results for Lead Vaccine Candidate against Chikungunya Fever in The Lancet". Vienna. |
2018-11-05 |
| Biocrates Life Sciences AG. (11/5/18). "Press Release: Biocrates Life Sciences AG Launches New Analytical Method for Functional Microbiome Research". Innsbruck. |
2018-11-05 |
| Validogen GmbH. (10/22/18). "Press Release: Change of Company Name – VTU Technology Is Now Validogen". Raaba-Grambach. |
2018-10-22 |
| Marinomed Biotech AG. (10/19/18). "Press Release: Initiation of First Marinosolv Clinical Trial (Ph III)". |
2018-10-19 |
| Apeiron Biologics AG. (9/19/18). "Press Release: Apeiron Announces Collaboration with Lead Discovery Center GmbH". Vienna. |
2018-09-19 |
| ViraTherapeutics GmbH. (9/13/18). "Press Release: Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies". Ingelheim. |
2018-09-13 |
| Haplogen Bioscience GmbH. (9/10/18). "Press Release: Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to Develop Novel Therapies in Severe Viral Diseases". Montréal, QC & Vienna. |
2018-09-10 |
| Marinomed Biotech AG. (8/29/18). "Press Release: Vienna-based Biotech Company Marinomed on a Growth Path". |
2018-08-29 |
| PhagoMed Biopharma GmbH. (8/28/18). "Press Release: Viruses against Bacteria. Development of Novel Therapeutics Boosted with Millions of Euros". Vienna. |
2018-08-28 |
| Apeiron Biologics AG. (8/28/18). "Press Release: Apeiron Expands Executive Board and Appoints Dr. Anderson Gaweco as Chief Medical and Scientific Officer (CMSO)". Vienna. |
2018-08-28 |
| Haplogen GmbH. (8/14/18). "Press Release: Haplogen Enters into a Collaboration with Bayer". Vienna. |
2018-08-14 |
| Marinomed Biotech AG. (7/31/18). "Press Release: Pascal Schmidt Appointed CFO as Vienna Based Biotech Firm Marinomed Strengthens Its Management Team – Company Reports Strong Growth". Vienna. |
2018-07-31 |
| Biocrates Life Sciences AG. (7/25/18). "Press Release: AAIC Researchers Report New Data on How Gut Bacteria and Lipid Metabolism May Influence Alzheimer’s and Other Brain Diseases". Innsbruck. |
2018-07-25 |
| Agilent Technologies Inc.. (7/18/18). "Press Release: Agilent and Grabner Instruments Provide Innovative Mobile Testing Solution for the Petroleum Industry". Santa Clara, CA. |
2018-07-18 |
| Apeiron Biologics AG. (7/17/18). "Press Release: Apeiron Appoints Peter Llewellyn-Davies as Chief Executive Officer". Vienna. |
2018-07-17 |
| Hookipa Biotech AG. (7/2/18). "Press Release: Hookipa Appoints Dr. Christoph Lengauer as a Non-Executive Director". Vienna. |
2018-07-02 |
| Freenome, Inc.. (6/28/18). "Press Release: Christian Doppler Research Grant Awarded to Freenome and the Medical University of Graz to Advance Understanding of Gene Expression Changes in Cancer Using Circulating Biomarkers". South San Francisco, CA & Graz |
2018-06-28 |
| Cellnovo. (6/14/18). "Press Release: Cellnovo Announces the Commercialisation of Insulin Cartridges Following the Successful Start of Large-scale Manufacturing at the Flex Facility in Althofen, Austria". Paris. |
2018-06-14 |
| BlueBee. (6/12/18). "Press Release: Lexogen and BlueBee Collaborate to Streamline QuantSeq-UMI Sequencing Data Analysis Pipeline". Vienna & Rijswijk. |
2018-06-12 |
| Themis Bioscience GmbH. (6/11/18). "Press Release: Themis Receives EMA PRIME Designation for Chikungunya Vaccine". Vienna. |
2018-06-11 |
| Hookipa Biotech AG. (6/5/18). "Press Release: Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop Immunotherapies Against HIV and Hepatitis B". Vienna & Foster City, CA. |
2018-06-05 |
| REPO-TRIAl Project. (5/31/18). "Press Release: REPO-TRIAL – a European Union Project for In Silico Trial-Based Drug Repurposing". Maastricht. |
2018-05-31 |
| Affiris AG. (5/14/18). "Press Release: Affiris Announces Encouraging Long-term Data from a Series of First-in-Human Studies Using Affitope PD01A Targeting Oligomeric Alpha-synuclein in Early Parkinsons Disease Patients". Vienna. |
2018-05-14 |
| bio.logis Genetic Information Management GmbH. (3/12/18). "Press Release: Personalized Medicine. Medical University of Vienna (MUW) to Collaborate with bio.logis GIM in Pharmacogenetics". |
2018-03-12 |
| Curetis N.V.. (3/6/18). "Press Release: Curetis Subsidiary Ares Genetics Wins Incubator Stay in Silicon Valley". Amsterdam & San Diego, CA & Holzgerlingen. |
2018-03-06 |
| BIA Separations d.o.o.. (3/5/18). "Press Release: BIA Separations and Nuvonis Technologies Partner to Support Vaccine and Gene Therapy Production". Ajdovšcina & Vienna. |
2018-03-05 |
| ViraTherapeutics GmbH. (3/5/18). "Press Release: ViraTherapeutics Starts Second Oncolytic Virus Development Program with Boehringer Ingelheim". Innsbruck. |
2018-03-05 |
| Affiris AG. (3/1/18). "Press Release: Affiris Announces Results of a Phase I Clinical Study Using Affitopes PD01A and PD03A, Confirming Safety and Tolerability for Both Compounds as well as Immunogenicity for PD01A in Early MSA patients". Vienna. |
2018-03-01 |
| Evotec AG. (1/8/18). "Press Release: Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi". Hamburg & Vienna. |
2018-01-08 |
| Themis Bioscience GmbH. (1/4/18). "Press Release: Themis Raises EUR 10 Million in Series C Financing to Advance Clinical Pipeline". Vienna. |
2018-01-04 |
| Biocrates Life Sciences AG. (1/3/18). "Press Release: Biocrates Life Sciences AG Acquires Metanomics Health GmbH to Create a New Global Leader in Metabolomics and Early Disease Detection". Innsbruck. |
2018-01-03 |
| Hookipa Biotech AG. (12/11/17). "Press Release: Hookipa Biotech Raises $60 Million (€50 Million) in an Oversubscribed Round C Financing". Vienna. |
2017-12-11 |
| Ionicon Analytik GmbH. (10/24/17). "Press Release: Ionicon Presents the New Charon Aerosol Inlet for PTR-TOFMS". Innsbruck. |
2017-10-24 |
| Hookipa Biotech AG. (10/18/17). "Press Release: Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors". Vienna. |
2017-10-18 |
| Apeiron Biologics AG. (10/13/17). "Press Release: Apeiron Strengthens Management Board with Industry Expert Peter Llewellyn-Davies as New Chief Financial Officer". Vienna. |
2017-10-13 |
| BIA Separations d.o.o.. (10/10/17). "Press Release: BIA Separations and Nuvonis Technologies Announce the signing of an Agreement to Collaborate on the Sales and Marketing of Their Technologies and Process Development Know-how". Ajdovšcina & Vienna. |
2017-10-10 |
| Ascenion GmbH. (10/9/17). "Press Release: Medical University Innsbruck Chooses Ascenion as Partner for Enhanced Knowledge and Technology Transfer". Munich. |
2017-10-09 |
| MorphoMed GmbH. (9/7/17). "Press Release: MorphoMed – New Start-up Focusing on Next-generation Tissue Engineering in Vienna". |
2017-09-07 |
| Allcyte GmbH. (9/4/17). "Press Release: Allcyte Collaborates with Boehringer Ingelheim to Advance Preclinical Oncology Drug Discovery by Using Novel Drug Response Profiling Technology". Vienna. |
2017-09-04 |
| European Invesmtent Bank (EIB). (8/28/17). "Press Release: Investment Plan for Europe – EIB Grants Financing to Apeiron". |
2017-08-28 |
| Merck & Co., Inc.. (8/7/17). "Press Release: MSD Animal Health to Purchase Manufacturing Facility in Krems, Austria. European Facility Will Boost Global Vaccine Production Capacity". Madison, NJ. |
2017-08-07 |
| Ionicon Analytik GmbH. (7/20/17). "Press Release: Ionicon Launches AMC-Monitor T-1000 for the Semiconductor Industry". Innsbruck. |
2017-07-20 |
| mySugr GmbH. (6/30/17). "Press Release: mySugr Joins the Roche family". San Diego, CA. |
2017-06-30 |
| Affiris AG. (6/20/17). "Press Release: Vaccine that Lowers Cholesterol in Mice Offers Hope of Immunising against Cardiovascular Disease". |
2017-06-20 |
| Themis Bioscience GmbH. (6/6/17). "Press Release: NIH and Themis Bioscience Announce the Initiation of a Clinical Trial of a Chikungunya Vaccine". Vienna. |
2017-06-06 |
| Thermo Fisher Scientific Inc.. (6/5/17). "Press Release: Thermo Fisher Scientific and Biocrates Life Sciences Launch Industry’s First Kit for Comprehensive Metabolome Analysis". Indianapolis, IN. |
2017-06-05 |
| ViraTherapeutics GmbH. (5/30/17). "Press Release: ViraTherapeutics Appoints Heinz Schwer as CEO". Innsbruck. |
2017-05-30 |
| Curetis N.V.. (5/24/17). "Press Release: Curetis Provides Business and Financial Update for the First Quarter 2017". Amsterdam & Holzgerlingen. |
2017-05-24 |
| AudioCure Pharma GmbH. (5/22/17). "Press Release: AudioCure Appoints Dr. Reimar Schlingensiepen as CEO". Berlin. |
2017-05-22 |
| Apeiron Biologics AG. (5/10/17). "Press Release: Marketing Approval for Children’s Cancer Immunotherapy in the EU". Vienna. |
2017-05-10 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [iito] Back into Ad 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-back-into-ad.jpg)
Date
![Picture [iito] No Content Marketing 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
